LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Sidow Joins Pivot Medical Board
People In The News

Sidow Joins Pivot Medical Board

September 6, 2013 1 min read Premium comments

Advertisement

Sidow Joins Pivot Medical Board
Kevin Sidow

Pivot Medical, Inc, a device company focusing on hip arthroscopy, has named Kevin Sidow to the company’s Board of Directors. Sidow, who is president and CEO of Moximed, Inc, has worked for more than 20 years in the orthopedic medical device market.

Prior to running Moximed, he was president and CEO of St. Francis Medical Technologies, Inc. a firm that developed treatments for degenerative spinal disorders. Kyphon purchased St. Francis Medical for $725 million in January 2007. Before joining St. Francis Medical, Sidow was the Worldwide President of DePuy, Inc. where he oversaw the global orthopedic, spine, trauma and sports medicine business.

“We are delighted to attract someone with Kevin’s experience and expertise in orthopedics to join the board of Pivot Medical. His insights will contribute substantially to Pivot’s commercial growth, ” said John J. Savarese, M.D., Chairman of Pivot. Other members serving on the Pivot Medical board are, Jack Giroux, Julian Nikolchev, John J. Savarese, Michael Lynn, John F. Maroney, and Guy L. Mayer.

Author

BW
Biloine W. Young
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy